U.S. flag

An official website of the United States government, Department of Justice.

Louisiana Enhanced Opioid Surveillance Initiative

Award Information

Award #
2017-PM-BX-K039
Location
Congressional District
Status
Past Project Period End Date
Funding First Awarded
2017
Total funding (to date)
$542,160

Description of original award (Fiscal Year 2017, $542,160)

The Harold Rogers Prescription Drug Monitoring Program (PDMP) is being incorporated into the FY 2017 Comprehensive Opioid Abuse Site-based Program. The purpose of this program is to improve collaboration and strategic decision-making of regulatory and law enforcement agencies and public health officials to address prescription drug and opioid misuse, save lives, and reduce crime. This is made possible through the collection and analysis of controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized state agency. The Comprehensive Opioid Abuse Site-based program was developed as part of the CARA legislation signed into law on July 22, 2016. In FY 2017, the Data-driven Responses to Opioid Abuse category of funding available through the PDMP grant program will provide funding and technical assistance to state agencies and units of local government located in states with existing and operational prescription drug monitoring programs and federally recognized Indian tribal governments. Funding must be used to form a multidisciplinary action group that may include (but is not limited to): the district attorney’s office, the state or local health department, state medical and pharmacy boards, police and sheriff departments, probation and parole, drug court representatives, child welfare representatives, local drug treatment providers, and community organizations. Grant funds may also be used to support a combination of the allowable use categories to develop multi-disciplinary projects that leverage key data sets; examine the impact of various policies and procedures on patient and community-level outcomes, and implement proven practices on a larger scale; identify geographic areas or populations at greatest risk for prescription drug and opioid misuse and overdose deaths and create data-driven responses at the local or state level; determine best practices for sharing data across diverse stakeholders; implement other innovative activities that demonstrate a multi-disciplinary, data-driven approach to addressing the opioid epidemic and assess the impact of specific policy or practice changes on PDMP utilization and/or patient or community-level outcomes.

The Louisiana Office of Behavioral Health is partnering with the Louisiana Commission on Law Enforcement and Administration of Criminal Justice to expand the Louisiana Opioid Surveillance System to include non-health data sources, to be built by third-party contractor GCR, Inc. The goals are to enhance surveillance of the opioid abuse continuum from pre- and post-legislative impacts, relationship between parolees, etc., to support data-driven methods for cross-system planning and collaboration, and to engage a stakeholder group to develop best practices for data sharing efforts. A multi-disciplinary action group will be formed to develop targeted interventions in select areas. Brandeis University assists in the evaluation of longitudinal data related to the PMP.

CA/NCF

Date Created: September 22, 2017